Building Health Care Capacity at Johnson & Johnson

Primary tabs

Building Health Care Capacity at Johnson & Johnson

In some areas of the world, people can’t get even basic health care services. Often, there aren’t enough health clinics or health care workers to meet communities’ growing needs. And in places where clinics and workers do exist, many health care teams don’t have access to training programs to build their skills. Learn about how we partner with several well-respected groups to provide leadership and development training for doctors, nurses and other health care professionals, and to give students opportunities to further their studies in health.

Content from this campaign

Distinct Innovation Model Sets Johnson & Johnson Apart
Innovation is the lifeblood to success for any company competing in the healthcare industry.  When it comes to innovation, many healthcare companies have robust, longstanding processes that are highly standardized and easily repeatable over time.  However, many of these innovation processes have one shortcoming – they are often front loaded — ie, the bulk of attention is given...
Feb 14, 2013 11:30 AM ET
Janssen Scientists Challenge Industry to Create Integrated Approaches to Healthcare Innovation
We’re pleased to share the news that a group of scientists and business leaders from our Janssen team, along with a professor from the Harvard Business School, co-authored a new commentary in the February issue of the journal Nature Reviews Drug Discovery that addresses integrated approaches to healthcare solutions. Husseini Manji,...
Feb 13, 2013 3:45 PM ET
Neglected Tropical Diseases – Not Neglected by Johnson & Johnson
By: Steven A. Silber, MD, Compound Developer Team Leader, Flubendazole One of the things that make me proud to be a Johnson & Johnson employee is the commitment and dedication of every person here to do the best we can for patients… especially for the world’s most...
Jan 25, 2013 12:30 PM ET
Janssen Announces Intent Not to Enforce Patents for Darunavir in Resource-Limited Settings
November 29, 2012 /3BL Media/ - The Janssen Pharmaceutical Companies of Johnson & Johnson today announced their intention not to enforce the patents they own and control on the antiretroviral (ARV) drug darunavir provided the darunavir product is medically acceptable and is used only in resource-limited settings.[1] This announcement is intended to assure generic...
Nov 29, 2012 3:00 PM ET
Introducing the Healthy Project
From Dr. Jack Groppel, Ph.D., co-founder of the Human Performance Institute, and Vice President of Applied Science and Performance Training at Wellness & Prevention, Inc., a Johnson & Johnson company. Today I joined a number of my colleagues at Johnson & Johnson and some of our partner organizations in New York City to introduce The...
Oct 23, 2012 4:30 PM ET

Pages